Advertisement
Canada markets open in 4 hours 22 minutes
  • S&P/TSX

    22,639.57
    -174.23 (-0.76%)
     
  • S&P 500

    5,427.13
    -128.61 (-2.31%)
     
  • DOW

    39,853.87
    -504.23 (-1.25%)
     
  • CAD/USD

    0.7231
    -0.0014 (-0.19%)
     
  • CRUDE OIL

    76.77
    -0.82 (-1.06%)
     
  • Bitcoin CAD

    89,028.25
    -2,766.99 (-3.01%)
     
  • CMC Crypto 200

    1,309.58
    -28.60 (-2.14%)
     
  • GOLD FUTURES

    2,375.30
    -40.40 (-1.67%)
     
  • RUSSELL 2000

    2,195.37
    -47.90 (-2.14%)
     
  • 10-Yr Bond

    4.2860
    +0.0470 (+1.11%)
     
  • NASDAQ futures

    19,194.25
    -9.00 (-0.05%)
     
  • VOLATILITY

    18.39
    +0.35 (+1.94%)
     
  • FTSE

    8,095.27
    -58.42 (-0.72%)
     
  • NIKKEI 225

    37,869.51
    -1,285.34 (-3.28%)
     
  • CAD/EUR

    0.6664
    -0.0016 (-0.24%)
     

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS). As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.